The largest database of trusted experimental protocols

Phobia, Specific

Phobia, Specific refers to an intense, persistent, and irrational fear of a specific object or situation, such as heights, animals, or certain types of situations.
These phobias can significantly interfere with an individual's daily life and activities.
PubCompare.ai's AI-driven platform can help optimize your research on Phobia, Specific by providing easy access to relevant protocols from literature, preprints, and patents, and leveraging intelligent comparisons to identify the best protocols and products for your research needs.
Experienece the power of PubCompare.ai's intellegent platform today and take your Phobia, Specific research to new heights.

Most cited protocols related to «Phobia, Specific»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Agoraphobia Alcohol Use Disorder Anxiety Disorders Cannabis Central Nervous System Stimulants Club Drugs Cocaine Conduct Disorder Diagnosis Disorder, Depressive Drug Use Disorders Dysthymic Disorder Hallucinogens Heroin Inhalation Drug Administration Manic Episode Mood Disorders Opioids Panic Disorder Pharmaceutical Preparations Phobia, Social Phobia, Specific Post-Traumatic Stress Disorder Sedatives Solvents Tobacco Products Tobacco Use Disorder Tranquilizing Agents

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2010
Abuse, Alcohol Adolescent Agoraphobia Alcoholic Intoxication, Chronic Anorexia Nervosa Anxiety Disorders Behavior Disorders Bulimia Nervosa Conduct Disorder Diagnosis Disorder, Attention Deficit-Hyperactivity Disorder, Binge-Eating Drug Abuse Drug Dependence Dysthymic Disorder Eating Disorders Emotions Interviewers Major Depressive Disorder Mental Disorders Mood Disorders Oppositional Defiant Disorder Panic Disorder Parent Phobia, Social Phobia, Specific Physical Examination Post-Traumatic Stress Disorder Problem Behavior Separation Anxiety Disorder Substance Use Disorders

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Adult Agoraphobia Alcohol Use Disorder Antisocial Personality Disorder Anxiety Disorders Asian Americans Drug Use Disorders Dysthymic Disorder Ethanol Ethics Committees, Research Face Hispanics Households Major Depressive Disorder Mania Mental Health Minority Groups Mood Mood Disorders Nicotine Use Disorder Panic Disorder Pharmaceutical Preparations Phobia, Specific Post-Traumatic Stress Disorder Social Anxiety Stress Disorders, Traumatic Substance Abuse Target Population Tobacco Products Tobacco Use Disorder Workers Wounds and Injuries
The Dunedin Study longitudinally ascertains mental disorders using a strategy akin to experience sampling: Every 2 to 6 years, we interview participants about past-year symptoms. Past-year reports maximize reliability and validity because recall of symptoms over longer periods has been shown to be inaccurate. It is possible that past-year reports separated by 1 to 5 years miss episodes of mental disorder occurring only in gaps between assessments. We tested for this possibility by using life-history calendar interviews to ascertain indicators of mental disorder occurring in the gaps between assessments, including inpatient treatment, outpatient treatment, or spells taking prescribed psychiatric medication (indicators that are salient and recalled more reliably than individual symptoms). Life-history calendar data indicated that virtually all participants having a disorder consequential enough to be associated with treatment have been detected in our net of past-year diagnoses made at ages 18, 21, 26, 32, and 38. Specifically, we identified only 11 people who reported treatment but had not been captured in our net of diagnoses from ages 18 to 38 (many of whom had a brief postnatal depression).
Symptom counts for the examined disorders were assessed via private structured interviews using the Diagnostic Interview Schedule (Robins, Cottler, Bucholz, & Compton, 1995 ) at ages 18, 21, 26, 32, and 38. Interviewers are health professionals, not lay interviewers. We studied DSM-defined symptoms of the following disorders that were repeatedly assessed in our longitudinal study (see Table S1 in the Supplemental Material available online): alcohol dependence, cannabis dependence, dependence on hard drugs, tobacco dependence (assessed with the Fagerström Test for Nicotine Dependence; Heatherton, Kozlowski, Frecker, & Fagerström, 1991 (link)), conduct disorder, MDE, GAD, fears/phobias, obsessive-compulsive disorder (OCD), mania, and positive and negative schizophrenia symptoms. Ordinal measures represented the number of the 7 (e.g., mania and GAD) to 10 (e.g., alcohol dependence and cannabis dependence) observed DSM-defined symptoms associated with each disorder (see Table S1 in the Supplemental Material). Fears/phobias were assessed as the count of diagnoses for simple phobia, social phobia, agoraphobia, and panic disorder that a study member reported at each assessment. Symptoms were assessed without regard for hierarchical exclusionary rules to facilitate the examination of comorbidity. Of the 11 disorders, 4 were not assessed at every occasion, but each disorder was measured at least three times (see Fig. 1 for the structure of psychopathology models and see Table S1 in the Supplemental Material).
Elsewhere we have shown that the past-year prevalence rates of psychiatric disorders in the Dunedin cohort are similar to prevalence rates in nationwide surveys of the United States and New Zealand (Moffitt et al., 2010 (link)). Of the original 1,037 study members, we included 1.000 study members who had symptom count assessments for at least one age (871 study members had present symptom counts for all five assessment ages, 955 for four, 974 for three, and 989 for two). The 37 excluded study members comprised those who died or left the study before age 18 or who had such severe developmental disabilities that they could not be interviewed with the Diagnostic Interview Schedule.
Publication 2013
Agoraphobia Alcoholic Intoxication, Chronic Cannabis Dependence Care, Ambulatory Conduct Disorder Depression, Postpartum Developmental Disabilities Diagnosis Drug Dependence Fear Health Personnel Hospitalization Interviewers Mania Mental Disorders Nicotine Dependence Obsessive-Compulsive Disorder Panic Disorder Pharmaceutical Preparations Phobia, Social Phobia, Specific Phobias Robins Schizophrenia Symptom Assessment Tobacco Dependence
We conducted parallel GWAS in nine samples of European ancestry and combined the results via meta-analysis. We applied two phenotypic strategies aimed at capturing common (pleiotropic) genetic effects shared across the five core ADs: GAD, PD, social phobia, agoraphobia, and specific phobias. We conducted two types of analyses in each sample based upon complementary approaches to modeling the comorbidity and common genetic risk across the ADs: (1) case-control (CC) comparisons, in which cases were designated as having “any AD” versus supernormal controls, and (2) quantitative factor scores (FS) estimated for every subject in the sample using confirmatory factor analysis.
Publication 2015
Agoraphobia Birth Europeans Genome-Wide Association Study Phenotype Phobia, Social Phobia, Specific

Most recents protocols related to «Phobia, Specific»

At 3 years and 12 years, maternal reports of internalising and anxiety problems in their children were obtained using the Child Behavior Checklist (CBCL) (for 1.5- to 5-year-olds29 and 6- to 18-year-olds30 ), a norm-referenced caregiver-completed rating scale that describes a child's functioning during the previous 6 months. All items are scored on a three-point Likert scale (0, not true; 1, somewhat or sometimes true; 2, very true or often true). All CBCL scales have a T-score mean of 50 and s.d. of 10 and different norms are provided for each gender across the age ranges of 6–11 years and 12–18 years. The CBCL yields a total problem score, externalising and internalising scores, and norm-referenced DSM-oriented scales, which include an anxiety problems scale. These DSM-oriented scales were created based on expert consensus of selected items from the CBCL and were developed to assist practitioners in the differential diagnostic process. The anxiety problems scale assesses symptoms of separation anxiety disorder, specific phobia and generalised anxiety disorder. There is substantial psychometric support for the various CBCL scales.30 ,31 For the current study, we used the internalising and anxiety problems T-scores, which are computed based on the gender and age of the child.
When their children were 6 years of age, mothers completed the MacArthur Health and Behavior Questionnaire (HBQ), which yielded measures of internalising, externalising, over-anxious and inattention behaviours. These measures were derived from the Ontario Child Health Study Measure, which maps onto items from the CBCL and DSM-III-R symptom criteria for internalising behaviours32 (link) in children ages 4 to 8 years.33 (link) We also used the Screen for Child Anxiety Related Emotional Disorders (SCARED),34 (link) a child and parent self-report instrument, to compare the mother's report of anxiety with that of their child, to examine whether mothers treated with a prenatal SSRI over-reported internalising and anxiety behaviours in their children.
Full text: Click here
Publication 2023
Anxiety Anxiety Disorders Child Children's Health Diagnosis Emotions Gender Microtubule-Associated Proteins Mothers Parent Phobia, Specific Psychometrics Separation Anxiety Disorder
This study is a secondary data analysis using data from a cross-sectional study which examined youth and parents of youth receiving tertiary mental healthcare in Ontario, Canada (Ferro et al., 2019 (link)). A detailed description of the procedures for this study which recruited participants from inpatient and outpatient mental health services has been previously published (Ferro et al., 2019 (link)). Inclusion criteria included: (1) children aged 4–17, (2) those who were currently receiving mental health services at an inpatient or outpatient setting, and (3) children who screened positive for at least one mental illness with the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID). The MINI-KID is a structured interview which assesses for presence of psychiatric illnesses following the DSM-IV and ICD-10 criteria (Sheehan et al., 2010 ). The MINI-KID assesses for the presence of internalizing disorders (major depressive episode, separation anxiety disorder, social phobia, specific phobia, generalized anxiety disorder) and externalizing disorders (attention deficit/hyperactivity disorder, oppositional defiant disorder, and conduct disorder). The validity and reliability of the MINI-KID are similar to established diagnostic interviews (Högberg et al., 2019 (link); Duncan et al., 2018 (link); McDonald et al., 2021 (link)). The parent report was used in these analyses. Parents needed sufficient English skills to be included, and youth who were restricted in their capacity to complete the questionnaires due to their current state of mental health were excluded.
Initially, 259 children were found to be eligible per the inclusion criteria. There was an initial response of 144 child-parent pairs (56%) who provided consent. One hundred pairs (39%) were enrolled in the study. Of the 100 parents, one did not complete the questionnaires and two had incomplete data and were removed from the analysis, leading to a final sample of 97 parent and child pairs (37%).
Publication 2023
Adolescent Anxiety Disorders Child Conduct Disorder Diagnosis Disorder, Attention Deficit-Hyperactivity Inpatient Mental Disorders Mental Health Mental Health Services Oppositional Defiant Disorder Outpatients Parent Phobia, Social Phobia, Specific Separation Anxiety Disorder Tertiary Healthcare Youth
To ensure the well-being of the participants, a preliminary evaluation of the treatment was carried out with psychologists with experience in patients with phobias in the Mexican population. This evaluation consisted of receiving feedback from phobic users on the treatment proposal and obtaining their perception of usefulness and experience of use regarding each gradual exposure therapy. The intention is to strengthen the content of the treatment using different types of multimedia to represent the object of fear and improve the interaction of the VTA. The details of the evaluation process and results can be consulted in González-Lozoya et al. (2021) [23 (link)]. A possible negative effect of our proposal exists when a wrong diagnosis is made regarding the severity level of the patient’s phobia. Should this occur, it would be possible for a patient to start treatment at a stage with a high intensity of phobic exposure, where she/he could experience a state of crisis and aggravate the phobia. To prevent this type of situation, the participant is asked to fill out a form with truthful data to evaluate a diagnosis (section IV of the ADIS-IV interview for specific phobias) to obtain the level of severity of the phobia and ensure that the initial stage of exposure is correct. To ensure this, the participant will receive detailed instructions through an explanatory and instructive video that will inform the importance of capturing the user’s data as accurately as possible, along with an initial call by the therapist as reinforcement to solve doubts and receive comments about the study. In case of an adverse event during the intervention, the participant will be withdrawn from the study and will receive personalized attention from the specialist to stabilize him/her.
Full text: Click here
Publication 2023
Attention Diagnosis Exposure Therapy Fear Patients Phobia, Specific Phobias Process Assessment, Health Care Reinforcement, Psychological Teaching

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Adjustment Disorders Agoraphobia Anxiety Disorders Bipolar Disorder Cyclothymic Disorder Disorder, Attention Deficit-Hyperactivity Disorder, Depressive Dysthymic Disorder Major Depressive Disorder Mania Melancholia Mental Disorders Mood Mood Disorders Obsessive-Compulsive Disorder Panic Disorder Phobia, Social Phobia, Specific Phobias Post-Traumatic Stress Disorder Schizoaffective Disorder Schizophrenia Separation Anxiety Disorder Stress Disorders, Traumatic, Acute Wounds and Injuries
The ABCD Study® is a longitudinal study of brain development and child health. The study design and recruitment strategy have previously been described [34 (link)], but in brief, the study used school-based recruitment to enrol 11,875 children from 21 metropolitan sites across the USA. Children were aged between 9 and 10 years at time of enrolment, and they and their caregiver completed the baseline visit between 1 October 2016 and 31 October 2018, which consisted of questionnaires, clinical interviews, neurocognitive interviews, and a neuroimaging protocol. Exclusionary diagnoses include a current diagnosis of schizophrenia, a moderate/severe autism diagnosis, intellectual disability, or alcohol/substance use disorder.
Our study received approval from the institutional review board of the University of Southern California. The ABCD Study obtained centralised institutional review board approval from the University of California, San Diego, and each of the 21 study sites obtained local institutional review board approval. Ethical regulations were followed during data collection and analysis. Parents or caregivers provided written informed consent, and children gave written assent. Data can be accessed through registration with the ABCD study at https://nda.nih.gov/abcd. The present analyses used data from the baseline (demographic information, co-occurring psychopathology) and follow-up phase one visits (SRS). A total of 11,878 children were recruited at baseline, and of these, 11,736 participated in sMRI scanning. As the ABCD cohort contains data from siblings, measures from a random sample of 7875 unrelated individuals were used, of which 345 were excluded due to poor quality sMRI data. Of the remaining 7521 participants, 7005 had available data on autistic traits, and thus made up the present sample. During the screening process, caregivers were asked if their child had previously received a diagnosis of a mental health condition. In the present sample, a total of 107 (1.53%) children were reported to have an autism diagnosis, and 1053 (15.03%) were reported to have a diagnosis of another mental condition including ADHD, depression, bipolar disorder, anxiety, or a specific phobia.
Full text: Click here
Publication 2023
Alcohol Use Disorder Anxiety Autistic Disorder Bipolar Disorder Brain Child Children's Health Disorder, Attention Deficit-Hyperactivity Ethics Committees, Research Intellectual Disability Mental Disorders Parent Phobia, Specific Respiratory Diaphragm Schizophrenia Sibling

Top products related to «Phobia, Specific»

Sourced in United States
SAS version 9.4 for Windows is a software application that provides a range of statistical and analytical capabilities. It is designed to run on the Windows operating system and offers a comprehensive set of tools for data management, analysis, and reporting. The software supports a variety of data formats and provides a user-friendly interface for accessing and manipulating data. SAS version 9.4 for Windows is a versatile tool that can be utilized for a wide range of applications, including business intelligence, predictive modeling, and scientific research.
Sourced in United States, Denmark, United Kingdom, Canada, Austria
Stata 11 is a comprehensive statistical software package developed by StataCorp. It provides a wide range of data management, analysis, and visualization tools for researchers, students, and professionals across various fields. Stata 11 offers a flexible and user-friendly interface to handle complex data, perform advanced statistical analyses, and generate high-quality reports and graphics.
Sourced in United States, Japan, Germany, United Kingdom, Belgium, Austria, Australia, China, Switzerland
SPSS Statistics 22 is a statistical software package developed by IBM. It provides tools for data management, analysis, and presentation. The software includes features for descriptive statistics, regression analysis, and hypothesis testing.
Sourced in United States
The CytoTune-iPS 2.0 Sendai Reprogramming Kit is a laboratory product designed for the efficient generation of induced pluripotent stem cells (iPSCs) from various cell types. The kit utilizes Sendai virus vectors to deliver reprogramming factors, facilitating the conversion of somatic cells into a pluripotent state.
Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United States, United Kingdom, Germany, Japan, Belgium, Austria, China, Denmark, Spain
SPSS 22.0 is a statistical software package developed by IBM. It is designed to analyze and manipulate data, providing users with a range of statistical tools and techniques for various applications, including market research, survey data analysis, and social science research.
Sourced in United States, Japan, United Kingdom, Germany, Belgium, Austria, Spain, France, Denmark, Switzerland, Ireland
SPSS version 20 is a statistical software package developed by IBM. It provides a range of data analysis and management tools. The core function of SPSS version 20 is to assist users in conducting statistical analysis on data.

More about "Phobia, Specific"

Phobias, Specific Phobia, Anxiety Disorders, Fear, Irrational Fear, Persistent Fear, Situational Phobia, CytoTune-iPS 2.0 Sendai Reprogramming Kit, SAS 9.4, SPSS 22, SPSS 20.
Specific phobias, also known as irrational or persistent fears, are intense and irrational fears of a particular object or situation.
These phobias can significantly interfere with an individual's daily life and activities.
Common examples include fear of heights (acrophobia), fear of animals (zoophobia), and fear of certain situations (situational phobia).
Researchers can leverage the power of PubCompare.ai's AI-driven platform to optimize their studies on specific phobias.
The platform provides easy access to relevant protocols from literature, preprints, and patents, while also facilitating intelligent comparisons to identify the best protocols and products for their research needs.
This can be particularly useful when working with tools like SAS 9.4, SPSS 22, SPSS 20, or the CytoTune-iPS 2.0 Sendai Reprogramming Kit, which are commonly used in phobia-related research.
By harnessing the capabilities of PubCompare.ai, researchers can take their specific phobia studies to new heights, gaining valuable insights and streamlining their research processes.
Experience the power of this intelligent platform today and unlock new possibilities for your phobia-related projects.